» Articles » PMID: 24596455

Discovery of Emphysema Relevant Molecular Networks from an A/J Mouse Inhalation Study Using Reverse Engineering and Forward Simulation (REFS™)

Overview
Publisher Sage Publications
Date 2014 Mar 6
PMID 24596455
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic obstructive pulmonary disease (COPD) is a respiratory disorder caused by extended exposure of the airways to noxious stimuli, principally cigarette smoke (CS). The mechanisms through which COPD develops are not fully understood, though it is believed that the disease process includes a genetic component, as not all smokers develop COPD. To investigate the mechanisms that lead to the development of COPD/emphysema, we measured whole genome gene expression and several COPD-relevant biological endpoints in mouse lung tissue after exposure to two CS doses for various lengths of time. A novel and powerful method, Reverse Engineering and Forward Simulation (REFS™), was employed to identify key molecular drivers by integrating the gene expression data and four measured COPD-relevant endpoints (matrix metalloproteinase (MMP) activity, MMP-9 levels, tissue inhibitor of metalloproteinase-1 levels and lung weight). An ensemble of molecular networks was generated using REFS™, and simulations showed that it could successfully recover the measured experimental data for gene expression and COPD-relevant endpoints. The ensemble of networks was then employed to simulate thousands of in silico gene knockdown experiments. Thirty-three molecular key drivers for the above four COPD-relevant endpoints were therefore identified, with the majority shown to be enriched in inflammation and COPD.

Citing Articles

Inferring Gene Networks for Strains of Dehalococcoides Highlights Conserved Relationships between Genes Encoding Core Catabolic and Cell-Wall Structural Proteins.

Mansfeldt C, Heavner G, Rowe A, Hayete B, Church B, Richardson R PLoS One. 2016; 11(11):e0166234.

PMID: 27829029 PMC: 5102406. DOI: 10.1371/journal.pone.0166234.


Transcriptional profiling and targeted proteomics reveals common molecular changes associated with cigarette smoke-induced lung emphysema development in five susceptible mouse strains.

Cabanski M, Fields B, Boue S, Boukharov N, DeLeon H, Dror N Inflamm Res. 2015; 64(7):471-86.

PMID: 25962837 PMC: 4464601. DOI: 10.1007/s00011-015-0820-2.

References
1.
Buist A, McBurnie M, Vollmer W, Gillespie S, Burney P, Mannino D . International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007; 370(9589):741-50. DOI: 10.1016/S0140-6736(07)61377-4. View

2.
Finlay G, ODriscoll L, Russell K, DArcy E, Masterson J, Fitzgerald M . Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med. 1997; 156(1):240-7. DOI: 10.1164/ajrccm.156.1.9612018. View

3.
Rangasamy T, Misra V, Zhen L, Tankersley C, Tuder R, Biswal S . Cigarette smoke-induced emphysema in A/J mice is associated with pulmonary oxidative stress, apoptosis of lung cells, and global alterations in gene expression. Am J Physiol Lung Cell Mol Physiol. 2009; 296(6):L888-900. PMC: 2692799. DOI: 10.1152/ajplung.90369.2008. View

4.
Terpstra G, de Weger R, Wassink G, Kreuknit J, Huidekoper H . Changes in alveolar macrophage enzyme content and activity in smokers and patients with chronic obstructive lung disease. Int J Clin Pharmacol Res. 1987; 7(4):273-7. View

5.
Beeh K, Beier J, Kornmann O, Buhl R . Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects. Respir Med. 2003; 97(6):634-9. DOI: 10.1053/rmed.2003.1493. View